On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is “Equitable access for all: recognizing all bleeding disorders”. The World Federation of Hemophilia (WFH) vision of ‘Treatment for All’ is for a world where all people with inherited bleeding disorders have access to care, regardless of their type of bleeding disorder, gender, age, or where they live.

This April, let’s celebrate our community and continue working towards a world where everyone—with hemophiliaA or B, von Willebrand disease (VWD) or any other bleeding disorder—has access to diagnosis, treatment, and comprehensive care.

World Hemophilia Day – WFH – World Federation of Hemophilia

ProFactor Pharma’s mission is to transform treatment availability for haemophilia A patients by providing a an affordable recombinant FVIII treatment to those who cannot access or afford the treatment. We are currently fundraising and looking for partners to progress with clinical trial medication manufacturing and a first clinical trial. 

ProFactor Pharma will be attending the WFH Congress in Madrid, Spain from April 21-24 and will also be present at BioTrinity April 23-24 in London with a pitch presentation by our CEO Jaymin Amin on Wed April 24, Science track 1, 11-11.20am (Cardiovascular & Metabolic Diseases R&D Spotlight).

BioTrinity 2024 | OBN (UK) Ltd‌ on Glue Up